Todd A. Hardy

Hospital Road
Concord, NSW 2139, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 21, 2026

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Journal: Internal medicine journal

Published: May 28, 2026

Diagnostic Approach to Presumptive Demyelinating Solitary CNS Lesions.

Diagnostic Approach to Presumptive Demyelinating Solitary CNS Lesions.

Journal: Continuum (Minneapolis, Minn.)

Published: April 02, 2026

Plasma proteome in LGI-1 autoimmune encephalitis.

Plasma proteome in LGI-1 autoimmune encephalitis.

Journal: Journal of neuroinflammation

Published: February 23, 2026

Inflammation induced by snake venoms optimizes envenomation.

Inflammation induced by snake venoms optimizes envenomation.

Journal: The Journal of physiology

Published: November 10, 2025

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Journal: Journal of neurology

Published: November 01, 2025

Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis.

Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis.

Journal: Brain communications

Published: October 01, 2025

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal: Journal of neurology

Published: September 16, 2025

Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomes.

Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomes.

Journal: Journal of the neurological sciences

Published: August 25, 2025

Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.

Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 19, 2025

Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Journal: BMJ neurology open

Published: August 10, 2025

COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 22, 2025

Showing 1-12 of 109

Last Updated: 09/26/2026